USE OF DOPAMINE PARTIAL AGONISTS FOR THE TREATMENT OF THE RESTLESS LEGS SYNDROME AND CORRESPONDING PHARMACEUTICAL PREPARATION

摘要

Disclosed is the oral use of dopamine partial agonists and the physiologically acceptable salts thereof in order to create a pharmaceutical preparation for treating the restless legs syndrome, which effectively controls the symptoms while having a significantly smaller undesired effect of a medicament than medicaments known in prior art.